A Study to Evaluate the Efficacy and Safety of UI022/UI023

Clinical trial NCT07600385 · COMPLETED

Trial details

NCT number: NCT07600385
Sponsor: Korea United Pharm. Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Peripheral Arterial Disease

Start date: 2019-03-12
Primary completion: 2022-05-03
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.